Zukela Ruzi

5 ta ish

University of Chinese Academy of Sciences, Beijing, China

1. Synthesis and anticancer activity of ethyl 5‐amino‐1‐<i>N</i>‐substituted‐imidazole‐4‐carboxylate building blocks

   Zukela Ruzi, Lifei Nie, Khurshed Bozorov +2

   MaqolaSynthesis and Characterization of Heterocyclic CompoundsArchiv der Pharmazie202111 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.073019

2. <scp>2‐substituted</scp> tricyclic oxazolo[5,4‐<i>d</i>]pyrimidine library: Design, synthesis, and cytotoxicity activity

   Yan Zeng, Lifei Nie, Khurshed Bozorov +4

   MaqolaQuinazolinone synthesis and applicationsJournal of Heterocyclic Chemistry202111 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.073023

3. Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action

   Zukela Ruzi, Khurshed Bozorov, Lifei Nie +2

   MaqolaSynthesis and biological activityBiomedicine & Pharmacotherapy20228 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.000121

4. Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties

   Zukela Ruzi, Khurshed Bozorov, Lifei Nie +2

   MaqolaSynthesis and biological activityBioorganic Chemistry20236 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.102665

5. Scaffold-Hopping Design and Synthesis of Thieno[3,2-d]pyrimidines: Anticancer Activity, Apoptosis Induction, and In Silico Inhibition of CDKs

   Zukela Ruzi, Anvarjon Buronov, Lifei Nie +7

   MaqolaSynthesis and biological activityInternational Journal of Molecular Sciences20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.000966